The FDA has approved Zuranolone, a groundbreaking pill for postpartum depression, promising noticeable improvements in as few as three days.
Unlike traditional treatments, Zuranolone directly targets the hormonal shifts post-childbirth, addressing a root cause often overlooked in conventional medicine.
Tag: Antidepressant Efficacy
“Peeling Back the Layers of Depression: Are We Asking the Right Questions?
As clinicians and scientists, we’re on the edge of our seats, waiting for this 60-item questionnaire to be available to the broader community. It promises to be a game-changer. It’s not just about providing a diagnosis or a treatment; it’s about empowering our patients with tools for self-assessment, helping them understand and articulate their journey.
Probiotics: A New Frontier in Depression Treatment
Considering root causes and potential contributing factors can lead to a more nuanced and comprehensive understanding of depression and anxiety.
L-Methylfolate: A Potential Boost to Antidepressant Efficacy
The evidence shows that patients receiving 15 mg/day of LMF for 30 days exhibited significantly greater reduction in Hamilton Depression Rating Scale (HDRS-17) scores and higher response rates compared to the placebo group. Additionally, a 12-month open extension trial indicated that 60% of initial non-responders eventually achieved remission with no serious adverse events.